News | November 13, 2021
Aster DM Healthcare PAT at Rs 107 cr. in Q2FY22
Aster DM Healthcare announced its financial results for the quarter ended September 30, 2021
Aster DM Healthcare announced its financial results for the quarter ended September 30, 2021
The Board of Directors of Alembic Pharmaceuticals have approved the unaudited consolidated financial results of the company for the period ended September 30, 2021.
The Board of Directors of AstraZeneca Pharma India have approved the unaudited consolidated financial results of the company for the period ended September 30, 2021
Strides Pharma Science has reported consolidated financial results for the period ended September 30, 2021
It plans to double its network to 50 centres across India in the next three years
More than 90,000 patients utilise the services daily
Its store network grew from 144 stores in March 2019 to 236 stores. It has a presence in 23 cities across Maharashtra, Goa and Karnataka, employing more than 4,600 people.
The global wellness market is valued at more than US $ 1.5 trillion, with annual growth of 5-10 per cent
BB will have access to 100 million doses of vaccines annually and commercialization rights of the SILS vaccine portfolio for global markets
_256_384.jpg)
In the period April to August 2021, exports stood at Rs 73,469.29 crores compared to Rs 72,275.22 crores for the period April to August 2020 a growth of 1.65 per cent
Subscribe To Our Newsletter & Stay Updated
